| Vial description: |
AHSG, FETUARO2743, Fetuin A |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 90% |
| Molecular weight: |
1 kDa, 36 |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P29699 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, His-tag) Antibody is a &alpha, This antibody needs to be stored at + 4°, - or alpha protein sometimes glycoprotein present in blood, C in a fridge short term in a concentrated dilution, The anti-Alpha-2-HS-glycoprotein / AHSG (19-345 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Conjugation: |
histidine |
| Gene target: |
His-tag), Alpha-2-HS-glycoprotein / AHSG (19-345 |
| Short name: |
His-tag) Antibody, anti-Alpha-2-HS-glycoprotein / AHSG (19-345 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
His |
| Alternative name: |
histidine-detection labelled) (Antibody to), antibody to-a-2-HS-glycoprotein / alpha-2-HS-glycoprotein (19-345 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
A2HS and AHS and FETUA and HSGA, AHSG and IDBG-634683 and ENSBTAG00000000522 and 280988, AHSG and IDBG-68916 and ENSG00000145192 and 197, Ahsg and IDBG-148706 and ENSMUSG00000022868 and 11625, Extracellular, kinase inhibitor activity, this GO :0001501 and skeletal system development and biological process this GO :0001503 and ossification and biological process this GO :0004869 and cysteine-type endopeptidase inhibitor activity and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006907 and pinocytosis and biological process this GO :0006953 and acute-phase response and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0019210 and kinase inhibitor activity and molecular function this GO :0030500 and regulation of bone mineralization and biological process this GO :0030502 and negative regulation of bone mineralization and biological process this GO :0042326 and negative regulation of phosphorylation and biological process this GO :0045087 and innate immune response and biological process this GO :0046627 and negative regulation of insulin receptor signaling pathway and biological process this GO :0050727 and regulation of inflammatory response and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component, this GO :0004869 : cysteine-type endopeptidase inhibitor activity, this GO :0004869 : cysteine-type endopeptidase inhibitor activity and also this GO :0019210 : kinase inhibitor activity, this GO :0019210 : kinase inhibitor activity, alpha-2-HS-glycoprotein |
| Identity: |
349 |
| Gene: |
AHSG |
More about : AHSG |
| Long gene name: |
alpha 2-HS glycoprotein |
| Synonyms: |
FETUA A2HS HSGA |
| Synonyms name: |
fetuin A |
| Locus: |
3q27, 3 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
D67013 M16961 |
| Entrez gene record: |
197 |
| Pubmed identfication: |
9322749 7736783 |
| RefSeq identity: |
NM_001622 |
| Classification: |
Cystatins, type 4 |
| Havana BLAST/BLAT: |
OTTHUMG00000156605 |